Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Metabolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02917863
What this trial is testing

Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism

Who this might be right for
Hypothyroidism
Meyer Children's Hospital IRCCS 70
Early research (Phase 1)Study completedNCT01779687
What this trial is testing

Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.

Who this might be right for
HIVHypercholesterolaemia
Radboud University Medical Center 24
Large-scale testing (Phase 3)Study completedNCT04560998
What this trial is testing

A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Peripheral Arterial Disease
Novo Nordisk A/S 792
Large-scale testing (Phase 3)Study completedNCT01214239
What this trial is testing

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 300
Not applicableUnknownNCT05792657
What this trial is testing

The ABEL Feasibility Study (Adherence, Better Health, Exercise and Life Satisfaction)

Who this might be right for
Obesity
Norges idrettshøgskole 200
Early research (Phase 1)Study completedNCT06559527
What this trial is testing

A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function

Who this might be right for
Diabetes Mellitus, Type 2ObesityOverweight
Novo Nordisk A/S 42
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Testing effectiveness (Phase 2)Looking for participantsNCT07415954
What this trial is testing

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 270
Early research (Phase 1)UnknownNCT03726866
What this trial is testing

Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

Who this might be right for
DyslipidemiasHypertension
Chong Kun Dang Pharmaceutical 30
Testing effectiveness (Phase 2)Study completedNCT02595983
What this trial is testing

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

Who this might be right for
Transthyretin (TTR)-Mediated AmyloidosisFamilial Amyloidotic Polyneuropathy (FAP)ATTR Amyloidosis+1 more
Alnylam Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT05328154
What this trial is testing

MAGnesium Effect With ANtiosteoporotic Drugs

Who this might be right for
Osteoporosis, Postmenopausal
University Hospital, Clermont-Ferrand 45
Not applicableStudy completedNCT00552994
What this trial is testing

Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients

Who this might be right for
Diabetes Mellitus
Odense University Hospital 150
Post-approval studies (Phase 4)Study completedNCT00245986
What this trial is testing

Effect of Genetics on Metabolism of Efavirenz

Who this might be right for
Metabolism
National Institutes of Health Clinical Center (CC) 350
Not applicableStudy completedNCT01669473
What this trial is testing

A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use

Who this might be right for
Diabetes Mellitus Type IDiabetes Mellitus Type II
Northwestern University 541
Early research (Phase 1)Study completedNCT00388986
What this trial is testing

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 18
Large-scale testing (Phase 3)Study completedNCT00002070
What this trial is testing

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Schering-Plough
Early research (Phase 1)Study completedNCT00625859
What this trial is testing

Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 27
Early research (Phase 1)Study completedNCT07102095
What this trial is testing

A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose

Who this might be right for
Hepatic InsufficiencyLiver DiseasesPharmacokinetics+1 more
Bayer 18
Not applicableStudy completedNCT01859598
What this trial is testing

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Who this might be right for
Diabetes
The George Institute for Global Health, China 19,894
Not applicableEnded earlyNCT05256875
What this trial is testing

An Analysis to Assess Non-adherence in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2HypertensionMedication Adherence
University of Leicester 90
Next Page